Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant

Nuland, M. van; Janssen, J.M.; Hoek, B. van; Rosing, H.; Beijnen, J.H.; Bergman, A.M. (2019)

Article / Letter to editor

• Hepatotoxicity
• Liver transplant
• Metabolite
• Prostate cancer
• Therapeutic drug monitoring

• All authors: Nuland, M. van; Janssen, J.M.; Hoek, B. van; Rosing, H.; Beijnen, J.H.; Bergman, A.M.
• Date: 2019-10-31
• Journal: Clinical Genitourinary Cancer
• Volume: 17
• Issue: 5
• Pages: E893 - E896
• DOI: doi:10.1016/j.clgc.2019.05.026